Codelivery of Emodin and Diammonium Glycyrrhizinate by Anti-alpha8 Integrin-Conjugated Immunoliposomes for the Treatment of Renal Fibrosis

Figure 5

Cell viability of NIH3T3 cells after treatment with blank liposomes (a) and various formulations (b). Cell viability of HBZY-1 cells after treatment with blank liposomes (c) and various formulations (d).

(a)

(b)

(c)

(d)